MedPage Today on MSN16h
JAK Inhibitor Succeeds in Giant Cell Arteritis TrialWASHINGTON -- Giant cell arteritis (GCA) can be successfully treated with the oral Janus kinase (JAK) inhibitor upadacitinib ...
Discover the results of a groundbreaking phase 3 trial presented at ACR 2024, showing upadacitinib's efficacy in managing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback